| Shelley R Moats, AUD | |
|
1050 E Market St Ste 1, Louisville, KY 40206-1874 | |
| (502) 588-9587 | |
| (502) 588-9580 |
| Full Name | Shelley R Moats |
|---|---|
| Gender | Female |
| Speciality | Audiologist |
| Location | 1050 E Market St Ste 1, Louisville, Kentucky |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1851384168 | NPI | - | NPPES |
| 50009966 | Other | KY | PASSPORT |
| 200864840 | Medicaid | IN | |
| 70001268 | Medicaid | KY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 231H00000X | Audiologist | 0465 (Kentucky) | Secondary |
| 237600000X | Audiologist-hearing Aid Fitter | 100528 (Kentucky) | Secondary |
| 231H00000X | Audiologist | 101740 (Kentucky) | Primary |
| Provider Name | Norton Childrens Medical Group Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1326695255 PECOS PAC ID: 3779917596 Enrollment ID: O20200102000758 |
News Archive
Bristol-Myers Squibb Company today announced that the U.S. Food and Drug Administration (FDA) has accepted for review a supplemental Biologics License Application (sBLA) for the subcutaneous formulation of ORENCIA® (abatacept), a treatment for adult patients with moderate to severe rheumatoid arthritis (RA) administered through an injection into the skin. Bristol-Myers Squibb submitted the sBLA to the FDA for the subcutaneous formulation of ORENCIA and received confirmation of its receipt on October 4, 2010.
Jens Pahnke and his team at the University of Oslo has recently published results in the prestigious scientific journal 'BRAIN' showing that decreased removal of toxic peptides in the brain causes the onset and first clinical signs of Alzheimer's disease, rather than overproduction as has previously been assumed. This information can now be used to target specific genes to enhance their function in the brain of elderly or people at risk.
A recent clinical trial found that the adult antiviral drug, tenofovir disoproxil fumarate (tenofovir DF), is safe and effective in treating adolescents with hepatitis B virus (HBV). Trial results published in the December issue of Hepatology, a journal of the American Association for the Study of Liver Diseases (AASLD), show that tenofovir DF suppressed HBV in 89% of pediatric participants.
IRIN examines exclusive breastfeeding practices in Kenya, writing, "The country's push for exclusive breastfeeding appears to be working; according to the 2009 Kenya Demographic and Health Survey, 32 percent of babies are exclusively breastfed up to the age of six months, up from just 13 percent in 2003." Kenya hopes "a new law banning the promotion of infant formula ... will contribute to the government's push to encourage all mothers to breastfeed exclusively for at least six months," the news service writes.
Viking Systems Inc. announced today that it has increased its cash and liquidity position through the issuance of common stock. The Company raised $934,897 by selling an aggregate of 4,398,050 shares of its common stock through its previously announced financing facility with Dutchess Opportunity Fund, II, LP.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Shelley R Moats, AUD Po Box 776879, Chicago, IL 60677-6879 Ph: (502) 588-9490 | Shelley R Moats, AUD 1050 E Market St Ste 1, Louisville, KY 40206-1874 Ph: (502) 588-9587 |
News Archive
Bristol-Myers Squibb Company today announced that the U.S. Food and Drug Administration (FDA) has accepted for review a supplemental Biologics License Application (sBLA) for the subcutaneous formulation of ORENCIA® (abatacept), a treatment for adult patients with moderate to severe rheumatoid arthritis (RA) administered through an injection into the skin. Bristol-Myers Squibb submitted the sBLA to the FDA for the subcutaneous formulation of ORENCIA and received confirmation of its receipt on October 4, 2010.
Jens Pahnke and his team at the University of Oslo has recently published results in the prestigious scientific journal 'BRAIN' showing that decreased removal of toxic peptides in the brain causes the onset and first clinical signs of Alzheimer's disease, rather than overproduction as has previously been assumed. This information can now be used to target specific genes to enhance their function in the brain of elderly or people at risk.
A recent clinical trial found that the adult antiviral drug, tenofovir disoproxil fumarate (tenofovir DF), is safe and effective in treating adolescents with hepatitis B virus (HBV). Trial results published in the December issue of Hepatology, a journal of the American Association for the Study of Liver Diseases (AASLD), show that tenofovir DF suppressed HBV in 89% of pediatric participants.
IRIN examines exclusive breastfeeding practices in Kenya, writing, "The country's push for exclusive breastfeeding appears to be working; according to the 2009 Kenya Demographic and Health Survey, 32 percent of babies are exclusively breastfed up to the age of six months, up from just 13 percent in 2003." Kenya hopes "a new law banning the promotion of infant formula ... will contribute to the government's push to encourage all mothers to breastfeed exclusively for at least six months," the news service writes.
Viking Systems Inc. announced today that it has increased its cash and liquidity position through the issuance of common stock. The Company raised $934,897 by selling an aggregate of 4,398,050 shares of its common stock through its previously announced financing facility with Dutchess Opportunity Fund, II, LP.
› Verified 6 days ago
Fawn E. Wujick, M.S. Audiologist Medicare: Medicare Enrolled Practice Location: 13403 Forest Springs Dr, Louisville, KY 40245 Phone: 502-693-1449 Fax: 188-851-1026 | |
Special Care Hearing Of Kentucky Llc Audiologist Medicare: Medicare Enrolled Practice Location: 12910 Shelbyville Rd, Louisville, KY 40243 Phone: 855-259-9183 Fax: 502-254-4069 | |
Mark Jeffrey Hales, MA CCC-A Audiologist Medicare: Not Enrolled in Medicare Practice Location: 4004 Dupont Cir, Ste 220, Louisville, KY 40207 Phone: 502-893-0159 | |
Brittany Ann Brose, AUD Audiologist Medicare: Accepting Medicare Assignments Practice Location: 401 E Chestnut St, Suite 710, Louisville, KY 40202 Phone: 502-583-8303 | |
Mr. Eric Scott Cahill, MS CCC-A Audiologist Medicare: Not Enrolled in Medicare Practice Location: 982 Eastern Pkwy, Building B, Louisville, KY 40217 Phone: 502-595-4459 | |
Special Care Hearing Of Indiana Llc Audiologist Medicare: Not Enrolled in Medicare Practice Location: 12910 Shelbyville Rd, Louisville, KY 40243 Phone: 855-259-9183 Fax: 502-254-4086 | |
Deanna S Brown, MS Audiologist Medicare: Not Enrolled in Medicare Practice Location: 2944 Breckenridge Ln, Louisville, KY 40220 Phone: 502-893-0159 Fax: 502-213-3892 |